Kamada (KMDA) Share-based Compensation (2012 - 2026)

Kamada (KMDA) posted quarterly Share-based Compensation of $800000.0 for Q1 2026, up 357.14% year-on-year from $175000.0 in Q1 2025, and up 127.92% on a QoQ basis from $351000.0 in Q4 2025.

Kamada (KMDA) Share-based Compensation (2012 - 2026) Analysis & Trends

Kamada (KMDA) has reported Share-based Compensation for 15 consecutive years, with $800000.0 the latest figure, recorded in Q1 2026.

  • Quarterly Share-based Compensation rose 357.14% year-over-year to $800000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 75.87% YoY) and the FY2025 annual result came in at $845000.0, down 74.42% from the prior year.
  • Share-based Compensation grew to $800000.0 in Q1 2026 per KMDA's latest filing, from $351000.0 in the prior quarter.
  • Over the last five years, Share-based Compensation for KMDA reached as high as $2.7 million in Q4 2023 and fell as low as $366.0 in Q3 2022.
  • A 5-year average of $362693.0 and a median of $214000.0 in 2023 frame the typical range for Share-based Compensation.
  • The largest YoY upside for Share-based Compensation was 85145.9% in 2023 against a maximum downside of 99.78% in 2023.
  • Year by year, Share-based Compensation stood at $25000.0 in 2022, then jumped by 10564.0% to $2.7 million in 2023, then plunged by 94.71% to $141000.0 in 2024, then surged by 148.94% to $351000.0 in 2025, then jumped by 127.92% to $800000.0 in 2026.
  • According to Business Quant data, Share-based Compensation over the past three periods registered $800000.0, $351000.0, and $117000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Share-based Compensation (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 43.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 25.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 125.69 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 58.30 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 56.50 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 55.70 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 21.00 Mn
10 Kamada 401.22 Mn 328.07 Mn 19.12 Mn 800,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 800,000.00
Mar 31, 2026 800,000.00
Dec 31, 2025 351,000.00
Dec 31, 2025 351,000.00
Sep 30, 2025 117,000.00
Sep 30, 2025 117,000.00
Jun 30, 2025 95,000.00
Jun 30, 2025 95,000.00
Mar 31, 2025 175,000.00
Mar 31, 2025 175,000.00
Dec 31, 2024 141,000.00
Dec 31, 2024 141,000.00
Sep 30, 2024 224,000.00
Sep 30, 2024 224,000.00
Jun 30, 2024 235,000.00
Jun 30, 2024 235,000.00
Mar 31, 2024 241,000.00
Mar 31, 2024 241,000.00
Dec 31, 2023 2.67 Mn
Dec 31, 2023 2.67 Mn